NHS National Proprietary Pharmaceuticals - Natalizumab Injection
e176264b1b5e11d06a7511331d4bcb42contractContracts Finder ↗Ref CF-1794100D0O000000rwimUAASME suitableclosed
Estimated value
£55.0m
Awarded value
—
Suppliers
0
Lots
1
0 awarded
Published
15 Aug 2023
Description
CM/PHR/23/5701 NHS National Proprietary Pharmaceuticals - Natalizumab Injection
Scope
- Reference
- CF-1794100D0O000000rwimUAA
- Total value
- £55,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Jan 2024 to 31 Dec 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)